4th Quarter - Report

MEHLMAN CONSULTING, INC. for ALVOTECH USA, INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Monitoring efforts involving patents and prescription drugs.

Foreign entity interest: As associated entities of Alvotech USA, Inc., Alvotech HF; Alvotech Holdings SA; Alovgen Lux Holdings Sarl; Aztiq Pharma Partners Sarl; and Robert Wessman have an interest in the issues above.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Monitoring efforts involving patents and prescription drugs. Promoting access to biosimilars. S.2891 - Restoring America Invents Act.

Foreign entity interest: As associated entities of Alvotech USA, Inc., Alvotech HF; Alvotech Holdings SA; Alovgen Lux Holdings Sarl; Aztiq Pharma Partners Sarl; and Robert Wessman have an interest in the issues above.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2891 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.